Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bioglan AB
AB
Active
Org 5567572119
Borrgatan 31, 211 24
Malmö
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2008
113 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Bioglan AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
SI
Simon Ingemar Björklund
Chief Executive Officer
Chief Executive Officer
2020
DM
Dragana Milutinovic Fällmar
Chief Auditor
Chief Auditor
2022
Former (1)
JM
Jacob Magnus Kvarnhammar
Chief Auditor
Chief Auditor
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
IB
Ignasi Biosca Reig
Board of Directors
2020
GR
Gabriel Roig Zapatero
Deputy Board Member
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
LABORATORIO REIG JOFRÉ SA
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bioglan AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network